ORACLE CORP (ORCL)       87.74  -0.79 (-0.89%)

87.74  -0.79 (-0.89%)

US68389X1054 - Common Stock - After market: 87.18 -0.56 (-0.64%)


Fundamental Rating

4

Taking everything into account, ORCL scores 4 out of 10 in our fundamental rating. ORCL was compared to 370 industry peers in the Software industry. While ORCL is still in line with the averages on profitability rating, there are some concerns on its financial health. ORCL is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

4

ORCL's Profit Margin of 19.09% is amongst the best of the industry. ORCL does better than the industry average Profit Margin of 12.03%.
ORCL has a Return On Assets of 6.85%. This is comparable to the industry average of 6.85%.

The Piotroski-F score of ORCL is 5.00. This is a neutral score and indicates average health and profitability for ORCL.
VS Industry

ROA (6.85%) VS Industry: 50% outperformed.

0.16
102.42

Profit Margin (19.09%) VS Industry: 72% outperformed.

0.30
902.32

Valuation

Valuation Rating

3

Compared to an average industry Price/Earning Ratio of 33.32, ORCL is valued a bit cheaper than its industry peers.
When comparing the Enterprise Value to EBITDA ratio of ORCL to the average industry ratio of 21.87, ORCL is valued rather cheaply.
The Price/Earnings Ratio is 17.87, which indicates a rather expensive current valuation of ORCL.

With a Forward Price/Earnings Ratio of 15.17, ORCL is valued correctly.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
VS Industry

Price/Earnings (17.87) VS Industry: 76% outperformed.

412.00
0.20

Enterprise Value/ EBITDA (16.83) VS Industry: 61% outperformed.

11,136.94
1.71

Growth

Growth Rating

6

Measured over the past 5 years, ORCL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.37% on average per year.
ORCL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.29%.
ORCL is expected to show quite a strong growth in Revenue. In the coming 5 years, the Revenue will grow by 11.12% yearly.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

The earnings per share for ORCL have decreased by -0.61% in the last year.
ORCL is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 9.71% yearly.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.
ORCL shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 2.35% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS12.37% 11.52% -0.61% 2.87% 8.52% 10.22% 9.71%
Revenue2.35% 2.42% 11.29% 16.96% 12% 10.61% 11.12%

Health

Health Rating

2

The Altman-Z score is in line with the industry averages, which is at 1.91.
The Piotroski-F score of ORCL is 5.00. This is a neutral score and indicates average health and profitability for ORCL.
A Current Ratio of 0.65 indicates that ORCL may have some problems paying its short term obligations.
Compared to an average industry Current Ratio of 1.76, ORCL is worse placed to pay its short term obligations than its industry peers. 87% of its industry peers have a better Current Ratio.

A Quick Ratio of 0.65 indicates that ORCL may have some problems paying its short term obligations.
Compared to an average industry Quick Ratio of 1.75, ORCL is worse placed to pay its short term obligations than its industry peers. 87% of its industry peers have a better Quick Ratio.
ORCL has an Altman-Z score of 1.39. This is a bad value and indicates that ORCL is not financially healthy and even has some risk of bankruptcy.
VS Industry

Quick Ratio (0.65) VS Industry: 13% outperformed.

0.06
83.89

Current Ratio (0.65) VS Industry: 13% outperformed.

0.06
83.89

Altman-Z (1.39) VS Industry: 45% outperformed.

-485.89
199.78

Dividend

Dividend Rating

5

The dividend of ORCL is nicely growing with an annual growth rate of 18.98%!
39.01% of the earnings are spent on dividend by ORCL. This is a low number and sustainable payout ratio.
ORCL has been paying a dividend for at least 10 years, so it has a reliable track record.
ORCL has a Yearly Dividend Yield of 1.47%. Purely for dividend investing, there may be better candidates out there.

Compared to an average industry Dividend Yield of 1.82, ORCL has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.42, ORCL is paying slightly less dividend.
ORCL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (1.47%) VS Industry: 41% outperformed.

0.23
11.11

ORACLE CORP87.74

NYSE:ORCL (2/7/2023, 7:04:00 PM)-0.79 (-0.89%)

After market: 87.18 -0.56 (-0.64%)

Chartmill FA Rating
GICS Sector Information Technology
GICS IndustryGroup Software & Services
GICS Industry Software
Earnings (Last) 12-12 2022-12-12/amc Earnings (Next) 03-08 2023-03-08/amc
Inst Owners 41.13% Inst Owner Change -0.85%
Ins Owners 42.65% Ins Owner Change 0%
Market Cap 236.57B Analysts 71.22
Price Target 94.61 (7.83%)

Dividend
Industry RankSector Rank
Dividend Yield 1.47%
Dividend Growth(5Y) 18.98% DP 39.01%
Div Incr Years 9 Div Non Decr Years 9
Ex-Date 01-09 2023-01-09 (0.32)

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) -2.56%
Min EPS beat(2) -5.78% Max EPS beat(2) 0.67%
EPS beat(4) 2 Avg EPS beat(4) -0.18%
Min EPS beat(4) -5.78% Max EPS beat(4) 10.14%
Revenue beat(2) N/A Avg Revenue beat(2) -1.08%
Min Revenue beat(2) -2.01% Max Revenue beat(2) -0.15%
Revenue beat(4) N/A Avg Revenue beat(4) -1.13%
Min Revenue beat(4) -2.01% Max Revenue beat(4) -0.15%
PT rev (1m) 3.41% PT rev (3m) 5.96%
EPS NQ rev (1m) -3.23% EPS NQ rev (3m) -3.26%
EPS NY rev (1m) 0% EPS NY rev (3m) 0.04%
Revenue NQ rev (1m) 0.77% Revenue NQ rev (3m) 0.77%
Revenue NY rev (1m) 0% Revenue NY rev (3m) 0.24%

Valuation
Industry RankSector Rank
PE 17.87
Fwd PE 15.17
P/S 5.13
P/FCF 28.18
P/OCF 15.69
P/B N/A
P/tB N/A
EV/EBITDA 16.83
EPS(TTM) 4.91 EY 5.6%
EPS(NY) 5.78 Fwd EY 6.59%
FCF(TTM) 3.11 FCFY 3.55%
OCF(TTM) 5.59 OCFY 6.37%
SpS 17.09 BVpS -1.57
TBVpS -28.69 PEG (NY) 6.23
PEG (5Y) 1.44

Profitability
Industry RankSector Rank
ROA 6.85%
ROE N/A
ROIC 12.6%
ROICexc 13.59%
ROICexgc 61.11%
OM 31.58%
PM 19.09%
GM 76.1%
ROICexgc(3y) 107.59% ROICexcg growth 3Y -45.79%
ROICexcg growth 5Y N/A ROICexc(3y) 22.01%
ROICexc growth 3Y -4.57% ROICexc growth 5Y -5%
OM growth 3Y 1.67% OM growth 5Y 0.9%
PM growth 3Y -17.37% PM growth 5Y -8.75%
GM growth 3Y -0.28% GM growth 5Y -0.3%
F-Score 5 Asset Turnover 0.36

Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 10.83
Debt/EBITDA 4.76
Cap/Depr 146.13%
Profit Quality 95.43%
Current Ratio 0.65
Quick Ratio 0.65
Altman-Z 1.39
F-Score 5 WACC 7.6%
ROIC/WACC 8.04 Cap/Depr(3y) 90.13%
Cap/Depr(5y) 77.92% Profit Quality(3y) 96.37%
Profit Quality(5y) 157.19%

Growth
EPS 1Y -0.61% EPS 3Y 11.52%
EPS 5Y 12.37% EPS growth Q2Q 0%
EPS Next Y 2.87% EPS Next 2Y 8.52%
EPS Next 3Y 10.22% EPS Next 5Y 9.71%
Revenue growth 1Y 11.29% Revenue growth 3Y 2.42%
Revenue growth 5Y 2.35% Revenue growth Q2Q 18.48%
Revenue Next Year 16.96% Revenue Next 2Y 12%
Revenue Next 3Y 10.61% Revenue Next 5Y 11.12%
EBIT growth 1Y -8.98% EBIT growth 3Y 4.13%
EBIT growth 5Y 3.27% EBIT Next Year 25.54%
EBIT Next 3Y 10.6% EBIT Next 5Y N/A
FCF growth 1Y -30.81% FCF growth 3Y -26.94%
FCF growth 5Y -16.11% OCF growth 1Y 7.92%
OCF growth 3Y -13.13% OCF growth 5Y -7.55%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA